Literature DB >> 7813494

Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

H F Guiot1, L J Corel, J M Vossen.   

Abstract

The prevalence of penicillin-resistant viridans streptococci was studied in healthy children and in paediatric and adult patients with leukaemia to determine whether the frequent presence of penicillin-resistant streptococci in the oral cavity of children with leukaemia is the result of antibiotic therapy. Twenty of the oral swabs from 50 healthy children who had not received antibiotics in the three months prior to sampling yielded viridans streptococci that could be cultured on blood agar containing 2 micrograms/ml benzyl-penicillin. In 11 of the 20 cases the streptococci were resistant to penicillin (MIC > or = 4 micrograms/ml). This prevalence is significantly higher than that found in adult leukaemia patients (40% vs. < or = 5%) but is about the same as that found in paediatric patients with leukaemia. The high prevalence of penicillin-resistant streptococci in the paediatric age group should be considered when selecting therapy and prophylaxis, especially when the risk of infection with one of these cocci is enhanced.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813494     DOI: 10.1007/bf01973990

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Unaltered penicillin susceptibility of streptococci; study of alpha hemolytic streptococci causing endocarditis, 1944 to 1954.

Authors:  C A BERNTSEN
Journal:  J Am Med Assoc       Date:  1955-01-22

2.  Clinical uses of currently available antibiotics.

Authors:  M FINLAND
Journal:  Br Med J       Date:  1953-11-21

3.  Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.

Authors:  M Venditti; P Baiocchi; C Santini; C Brandimarte; P Serra; G Gentile; C Girmenia; P Martino
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

4.  Streptococcal sepsis in bone marrow transplant patients.

Authors:  J Henslee; B Bostrom; D Weisdorf; N Ramsay; P McGlave; J Kersey
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

5.  Penicillin tolerance and bacterial endocarditis.

Authors:  Y Holloway; J Dankert; J Hess
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

6.  Alpha-hemolytic streptococci: clinical significance in the cancer patient.

Authors:  P A Pizzo; S Ladisch; F G Witebsky
Journal:  Med Pediatr Oncol       Date:  1978

7.  Penicillin resistance of nonhemolytic streptococci from rheumatic children receiving prophylactic penicillin.

Authors:  E KRUMWIEDE
Journal:  Pediatrics       Date:  1949-11       Impact factor: 7.124

8.  Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.

Authors:  J Cohen; J P Donnelly; A M Worsley; D Catovsky; J M Goldman; D A Galton
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

Review 9.  Selective decontamination in bone marrow transplant recipients.

Authors:  H F Guiot; R van Furth
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

10.  Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections.

Authors:  S J Weisman; F J Scoopo; G M Johnson; A J Altman; J J Quinn
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

View more
  5 in total

1.  All detectable high-molecular-mass penicillin-binding proteins are modified in a high-level beta-lactam-resistant clinical isolate of Streptococcus mitis.

Authors:  A Amoroso; D Demares; M Mollerach; G Gutkind; J Coyette
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.

Authors:  S J Rosser; M J Alfa; S Hoban; J Kennedy; G K Harding
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

3.  Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.

Authors:  H P Endtz; J W Mouton; J G den Hollander; N van den Braak; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.

Authors:  E Cercenado; M D Díaz; C Sánchez-Carrillo; T Vicente; J C Bernaldo de Quirós
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 5.  Alpha-hemolytic streptococci: a major pathogen of iatrogenic meningitis following lumbar puncture. Case reports and a review of the literature.

Authors:  P M Schneeberger; M Janssen; A Voss
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.